• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Godavari Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4985.0
  • ISIN : INE362C01012
107.89 -1 (-1.02%)
  • As on 23 Sep 2026 (EOD)

  • Today’s Low

    107.70

  • Today’s High

    114.00

  • Open

    114.00

  • Perv Close

    109.00

  • 52W Low

    69.70

  • 52W High

    135.25

Key Indicators

  • P/E(TTM)

    30.31

  • Mar.Cap (₹Cr.)

    117.75

  • Div & Yield %

    0.00

  • Book Value(₹)

    71.05

  • Debt-Equity Ratio

    -1.02

  • AGM Date

    22-Sep-2026

  • EPS

    3.56

  • P/E Ratio

    30.31

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    117.75

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.91

  • BV (₹)

    71.10

  • Sales( ₹ in Cr.)

    105.81

  • NP (in Cr.)

    3.66

  • NP Var(%)

    -16.0

  • Div%

    0.0

  • CPS (₹)

    5.60

  • EPS (₹)

    3.40

  • Traded Value (₹ in Lakhs)

    117.75

  • 52 Week High

    135.25

  • 52 Week Low

    69.70

  • Price BSE

    108.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    117.75

  • P/C Ratio

    19.40

  • P/E Ratio

    32.20

  • Price Vs.BV

    3.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 105.81 113.35 156.71 159.62 161.11 122.67
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 105.81 113.35 156.71 159.62 161.11 122.67
Other Income 1.16 0.98 0.62 0.88 0.28 0.41
Stock Adjustments 11.39 3.58 1.14 9.76 -2.48 -2.44
Total Income 118.36 117.91 158.47 170.26 158.91 120.64
EXPENDITURE :            
Raw Materials 88.89 85.24 121.95 137.82 127.97 94.15
Power and Fuel Cost 5.09 6.92 8.51 6.66 5.46 4.76
Employee Cost 5.70 5.03 5.13 4.84 4.96 3.94
Other Manufacturing Expenses 2.39 3.19 3.07 3.27 4.14 3.15
Selling and Administration Expenses 1.78 1.46 1.50 1.27 1.38 1.24
Miscellaneous Expenses 3.05 3.27 4.47 5.60 3.42 3.16
Employee Benefit Expenses 5.70 5.03 5.13 4.84 4.96 3.94
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 106.89 105.10 144.64 159.47 147.33 110.39
Operating Profit 11.48 12.80 13.84 10.81 11.57 10.25
Interest 3.98 4.73 4.92 3.93 2.85 3.32
Gross Profit 7.50 8.07 8.92 6.88 8.72 6.93
Depreciation 2.43 2.45 1.99 1.94 1.70 1.22
Profit Before Tax 5.07 5.62 6.93 4.94 7.02 5.71
Current Tax 1.09 1.19 1.16 1.02 1.23 1.19
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.12 0.06 0.22 0.13 0.55 0.39
Reported Net Profit 4.09 4.38 5.55 3.79 5.25 4.13
Extraordinary Items 0.43 0.04 -0.07 0.18 0.00 0.00
Adjusted Net Profit 3.66 4.34 5.62 3.61 5.25 4.13
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 24.47 20.09 14.54 10.75 5.51 1.38
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 28.56 24.47 20.09 14.54 10.75 5.51
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 4.04 5.82 7.37 5.03 6.97 5.48
Earnings Per Share(Adj)-Unit Curr 4.04 5.82 7.37 5.03 6.97 5.48
Book Value 69.66 57.56 51.74 44.38 39.35 32.38
Book Value(Adj)-Unit Curr 69.66 57.56 51.74 44.38 39.35 32.38

Shareholding Pattern

  • Promoter Group

    40.23%

  • Public Share Holding

    59.77%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,074,091 40.23 4,074,091 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,074,091 40.23 4,074,091 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 37,500 0.37 0 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 127,363 1.26 127,363 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 112,360 1.11 112,360 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 277,223 2.74 239,723 6
2] Non Institution
Bodies Corporate 811,136 8.01 766,136 49
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 394,282 3.89 179,382 130
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 240,639 2.38 240,639 101
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,437,320 24.07 2,435,220 37
Individuals holding nominal share capital up to Rs. 1 lakh 1,892,744 18.69 1,701,691 6,388
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,776,121 57.03 5,323,068 6,705
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,127,435 100.00 9,636,882 6,722

Company Background

Godavari Drugs LtdPharmaceuticals - Indian - Bulk Drugs

  • Godavari Drugs Ltd
  • BSE Code : 4985.0
  • ISIN : INE362C01012

  • Incorporation Year

    1987

  • Registered Office

    Mayfair 1-8-303-34
    Sardar Patel Road, Secunderabad,
    Andhra Pradesh-500003

  • Telephone

    91-40-27849700/27844557

  • FAX

    91-40-27849859

  • Chairman

    Ghanshyam Jaju

  • Managing Director

    Mukund Kakani

  • Company Secretary

    Venkatesh Achanta

  • Auditor

    Ayyadevara & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    CIL Securities Limited
    214 RaghavaRatna Tow,
    Chiragali Lane,Abids
    Mumbai - Hyderabad 500001

Godavari Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Godavari Drugs 107.89 106.61 105.81 28.32 6.77
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77